InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-16 · accession 0001225208-23-006012 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-17 2023-05-16 BSX Fitzgerald Joseph Michael EVP, Group Pres, Cardiology M - OptEx $13.08 +56.9K 277.2K +26% +$744.5K
D 2023-05-17 2023-05-16 BSX Fitzgerald Joseph Michael EVP, Group Pres, Cardiology S - Sale+OE $53.60 -63.3K 213.9K -23% -$3.39M
D 2023-05-17 2023-05-16 BSX Fitzgerald Joseph Michael EVP, Group Pres, Cardiology M - OptEx $0.00 -56.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-16 M A 56,921 $13.08 277,198 D — —
2 Common Common Stock 2023-05-16 S D 63,339 $53.60 213,859 D — — (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.37 to $53.80, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Derivative Stock Option (Right to Buy) 2023-05-16 M D 56,921 $0.00 0 D $13.08 · — to 2024-02-24 56,921 Common Stock (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.